has subject area Aged Aged, 80 and over Angiogenesis Inhibitors Antibodies, Monoclonal, Humanized Bevacizumab Female Humans Intraocular Pressure Intravitreal Injections Male Middle Aged Ocular Hypertension Ranibizumab Retrospective Studies Vascular Endothelial Growth Factor A